chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: Sore arm within several hours; Severe nausea; Moderate chills; Moderate body aches; Moderate headache; Exhaustion; Fever; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153), via an unspecified route of administration in the left arm on 10Apr2021 at 09:00 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to penicillin. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 19:00, the patient experienced sore arm within several hours, severe nausea, moderate chills, moderate body aches, moderate headache and exhaustion. On 10Apr2021 at 17:00, 8 hours after vaccination, the patient experienced fever. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sore arm, severe nausea, moderate chills, moderate body aches, moderate headache, exhaustion and fever were not resolved at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Sore arm within several hours; Severe nausea; Moderate chills; Moderate body aches; Moderate headache; Exhaustion; Fever; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153), via an unspecified route of administration in the left arm on 10Apr2021 at 09:00 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to penicillin. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 19:00, the patient experienced sore arm within several hours, severe nausea, moderate chills, moderate body aches, moderate headache and exhaustion. On 10Apr2021 at 17:00, 8 hours after vaccination, the patient experienced fever. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sore arm, severe nausea, moderate chills, moderate body aches, moderate headache, exhaustion and fever were not resolved at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Injection site pain; Fever; Chills; Muscle pain; Joint pain; Extreme tiredness; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 07Apr2021 at 15:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left leg on 17Mar2021 at 17:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. On 08Apr2021 at 04:00, the patient experienced injection site pain, fever, chills, muscle and joint pain, extreme tiredness and headache. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events injection site pain, fever, chills, muscle and joint pain, extreme tiredness and headache was recovering at the time of the report.   No follow-up attempts are possible; information about the lot number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Injection site pain; Fever; Chills; Muscle pain; Joint pain; Extreme tiredness; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 07Apr2021 at 15:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left leg on 17Mar2021 at 17:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. On 08Apr2021 at 04:00, the patient experienced injection site pain, fever, chills, muscle and joint pain, extreme tiredness and headache. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events injection site pain, fever, chills, muscle and joint pain, extreme tiredness and headache was recovering at the time of the report.   No follow-up attempts are possible; information about the lot number cannot be obtained. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Insomnia, Pain
Clinical narrative: fever at 101 f; Body aches; chills; sleeplessness; head ache; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 07:30 as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) from an unknown start date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took codeine and experienced allergy.  The patient also previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 07:15 as a single dose for COVID-19 immunisation. On 10Apr2021 at 00:00, one day after vaccination, the patient experienced fever at 101 Fahrenheit, body aches, chills, sleeplessness and headache. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fever at 101 Fahrenheit, body aches, chills, sleeplessness and headache was resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever at 101 f; Body aches; chills; sleeplessness; head ache; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 07:30 as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) from an unknown start date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took codeine and experienced allergy.  The patient also previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 07:15 as a single dose for COVID-19 immunisation. On 10Apr2021 at 00:00, one day after vaccination, the patient experienced fever at 101 Fahrenheit, body aches, chills, sleeplessness and headache. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fever at 101 Fahrenheit, body aches, chills, sleeplessness and headache was resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Heart rate increased, Hyperkeratosis, Injection site pruritus, Musculoskeletal pain
Clinical narrative: Itchy @15min mark, 2hr mark, 12hr mark, 36-72 hr mark.; Increased heat rate @ 15 min mark,12 hr mark.; Mild chest pain right arm down to right butt cheek pain @ 7 day mark.; Mild chest pain right arm down to right butt cheek pain @ 7 day mark.; Mild chest pain right arm down to right butt cheek pain @ 7 day mark.; Cheek pain/Mild chest pain right arm down to rightbutt cheek pain @ 7 day mark.; Injection site itchy & sore callous @ 8 day mark.; Injection site itchy & sore callous @ 8 day mark.; This is a spontaneous report from a contactable other healthcare professional.  A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PfizevER8732) via an intramuscular route of administration in the right arm on 30Mar2021 at 08:15 as a single dose for COVID-19 immunisation. Medical history included chronic sinus (chronic sinusitis). Concomitant medications were not reported. The patient had allergies to medications, food or other products (unspecified).  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021 at 08:45, the patient experienced itchy at 15min mark, 2hr mark, 12hr mark, 36-72 hr mark and increased heart rate at 15 min mark, 12 hr mark. On an unknown date in Mar2021, the patient experienced mild chest pain right arm down to right butt cheek pain @ 7-day mark, injection site itchy and sore callus at 8day mark. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events itchy at 15min mark, 2hr mark, 12hr mark, 36-72 hr mark, increased heart rate at 15 min mark, 12 hr mark, mild chest pain right arm down to right butt cheek pain @ 7-day mark, injection site itchy and sore callus at 8day mark was recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pruritus
Clinical narrative: Itchy @15min mark, 2hr mark, 12hr mark, 36-72 hr mark.; Increased heat rate @ 15 min mark,12 hr mark.; Mild chest pain right arm down to right butt cheek pain @ 7 day mark.; Mild chest pain right arm down to right butt cheek pain @ 7 day mark.; Mild chest pain right arm down to right butt cheek pain @ 7 day mark.; Cheek pain/Mild chest pain right arm down to rightbutt cheek pain @ 7 day mark.; Injection site itchy & sore callous @ 8 day mark.; Injection site itchy & sore callous @ 8 day mark.; This is a spontaneous report from a contactable other healthcare professional.  A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PfizevER8732) via an intramuscular route of administration in the right arm on 30Mar2021 at 08:15 as a single dose for COVID-19 immunisation. Medical history included chronic sinus (chronic sinusitis). Concomitant medications were not reported. The patient had allergies to medications, food or other products (unspecified).  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021 at 08:45, the patient experienced itchy at 15min mark, 2hr mark, 12hr mark, 36-72 hr mark and increased heart rate at 15 min mark, 12 hr mark. On an unknown date in Mar2021, the patient experienced mild chest pain right arm down to right butt cheek pain @ 7-day mark, injection site itchy and sore callus at 8day mark. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events itchy at 15min mark, 2hr mark, 12hr mark, 36-72 hr mark, increased heart rate at 15 min mark, 12 hr mark, mild chest pain right arm down to right butt cheek pain @ 7-day mark, injection site itchy and sore callus at 8day mark was recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: Vomit and diarrhea began at approximately 11pm.; diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 09:45(at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 20Mar2021 at 09:45(at the age of 59-years-old) as a single dose for COVID-19 immunisation and also allergic to codeine (MANUFACTURER UNKNOWN). On 10Apr2021 at 23:00, the patient experienced vomit and diarrhea. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vomit and diarrhea were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Headache; Tiredness/ the general feeling of tiredness; Muscle pain; Chills; Night sweats; Joint pain; Low-grade fever; Dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6208) via an unspecified route of administration in the left arm on 08Apr2021 at 14:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included triamcinolone acetonide (NASACORT) from an unknown date for an unspecified indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6206) via an unspecified route of administration in the right arm on 16Mar2021 at 19:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 10Apr2021 at 07:00, the patient experienced headache, tiredness, muscle pain, chills, night sweats, joint pain, low-grade fever, dizziness, and the general feeling of tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event headache, tiredness, muscle pain, chills, night sweats, joint pain, low-grade fever, dizziness, and the general feeling of tiredness were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Night sweats, Pyrexia
Clinical narrative: Headache; Tiredness/ the general feeling of tiredness; Muscle pain; Chills; Night sweats; Joint pain; Low-grade fever; Dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6208) via an unspecified route of administration in the left arm on 08Apr2021 at 14:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included triamcinolone acetonide (NASACORT) from an unknown date for an unspecified indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6206) via an unspecified route of administration in the right arm on 16Mar2021 at 19:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 10Apr2021 at 07:00, the patient experienced headache, tiredness, muscle pain, chills, night sweats, joint pain, low-grade fever, dizziness, and the general feeling of tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event headache, tiredness, muscle pain, chills, night sweats, joint pain, low-grade fever, dizziness, and the general feeling of tiredness were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Vomiting
Clinical narrative: Nauseous; Diarrhea; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 14:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient was not allergic to medications, food, or other products. Concomitant medications included NEW CHAPTER PERFECT POST NATAL, ATRANTIL and Cannabidiol (CBD) oil. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 15:00, 24 hours after shot, the patient started feeling very nauseous and then she had diarrhea and vomiting. The nausea stayed for 4 days. she was not sure if this was from the vaccine or not. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events diarrhea and vomiting was not resolved. The clinical outcome of the event nausea was resolved on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Headache, Myalgia, Pyrexia
Clinical narrative: Hands shaking; fever 100; severe headache; Muscle pain; Joint pain; This is a spontaneous report from a contactable nurse, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9266) via an unspecified route of administration in the left arm on 23Feb2021 at 09:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, osteoarthritis and hypothyroidism. The patient did not have allergy to any medications, food, or other products. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN), olmesartan medoxomil (BENICAR) and thyroid (ARMOUR THYROID). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN9581) via an unspecified route of administration in the left arm on 02Feb2021 at 09:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Feb2021 at 21:00, the patient experienced hands shaking, fever 100, severe headache, muscle and joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events hands shaking, fever 100, severe headache, muscle pain and joint pain were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Hands shaking; fever 100; severe headache; Muscle pain; Joint pain; This is a spontaneous report from a contactable nurse, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9266) via an unspecified route of administration in the left arm on 23Feb2021 at 09:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, osteoarthritis and hypothyroidism. The patient did not have allergy to any medications, food, or other products. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN), olmesartan medoxomil (BENICAR) and thyroid (ARMOUR THYROID). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN9581) via an unspecified route of administration in the left arm on 02Feb2021 at 09:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Feb2021 at 21:00, the patient experienced hands shaking, fever 100, severe headache, muscle and joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events hands shaking, fever 100, severe headache, muscle pain and joint pain were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Bone pain, Discomfort, Headache, Lymphadenopathy
Clinical narrative: Pain radiating to side boob down 6 inches.  pain 9 to the touch on scale of 10.2 large "golf ball sized' lymph nodes.  Not joking); Achy bones; Achy muscles; Feeling of body heaviness; Headache: throbbing; Severe chronic pain in armpit; This is a spontaneous report from a contactable healthcare professional, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 12Apr2021 at 15:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism/Hashimoto. The patient was allergic to surgical metals, pet dander and latex. Concomitant medications included levothyroxine sodium (SYNTHROID), liothyronine sodium (CYTOMEL) and losartan (MANUFACTURER UNKNOWN) all from an unknown date for an unknown indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the arm left on 22Mar2021 at 14:00 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 10:00, the patient experienced severe chronic pain in left armpit: pain radiating to side boob down 6 inches, pain 9 to the touch on scale of 10.2 large "golf ball sized' lymph nodes. " Not joking") In addition, achy bones, muscles and feeling of body heaviness.  Headache: throbbing, she felt like shit. The event resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events armpit pain, swollen lymph nodes, ache, muscle pain, discomfort and throbbing headache was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Pain radiating to side boob down 6 inches.  pain 9 to the touch on scale of 10.2 large "golf ball sized' lymph nodes.  Not joking); Achy bones; Achy muscles; Feeling of body heaviness; Headache: throbbing; Severe chronic pain in armpit; This is a spontaneous report from a contactable healthcare professional, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 12Apr2021 at 15:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism/Hashimoto. The patient was allergic to surgical metals, pet dander and latex. Concomitant medications included levothyroxine sodium (SYNTHROID), liothyronine sodium (CYTOMEL) and losartan (MANUFACTURER UNKNOWN) all from an unknown date for an unknown indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the arm left on 22Mar2021 at 14:00 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 10:00, the patient experienced severe chronic pain in left armpit: pain radiating to side boob down 6 inches, pain 9 to the touch on scale of 10.2 large "golf ball sized' lymph nodes. " Not joking") In addition, achy bones, muscles and feeling of body heaviness.  Headache: throbbing, she felt like shit. The event resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events armpit pain, swollen lymph nodes, ache, muscle pain, discomfort and throbbing headache was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Achy all over; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 12:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergy to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 the patient experienced achy all over. Therapeutic measures were not taken as a result of the event achy all over. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event achy all over was resolved on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Dizziness, Dry eye, Eye pain
Clinical narrative: Pregnant at the time of vaccination?: Yes; chills; Right arm stiff and sore; Right arm stiff and sore; dry painful eyes; dry painful eyes; dizziness (off balance); sweats; headache; tired; sore throat; dizziness (off balance); This is a spontaneous report from a Contactable consumer. This 37-years-old Female consumer reported for herself. A 37-year-old pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: ER2613) via an unspecified route of administration in arm left on 13Apr2021 08:45 as dose 2, single (age at vaccination: 37 years) for COVID-19 immunisation. Medical history included known allergies: nuts, IIH, epilepsy, psoriatic arthritis, RA, hashimoto's, hypertension, all from an unknown date and unknown if ongoing. Concomitant medications included certolizumab pegol (CIMZIA); hydroxychloroquine phosphate (PLAQUENIL [HYDROXYCHLOROQUINE PHOSPHATE]); levetiracetam dihydrochloride (KEPPRA [LEVETIRACETAM DIHYDROCHLORIDE]); labetalol hydrochloride (LABETALOL HYDROCHLORIDE); acetazolamide (DIAMOX [ACETAZOLAMIDE]); levothyroxine sodium (SYNTHROID), all taken for an unspecified indication, start and stop date were not reported. Historical vaccine included bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EN6208) via an unspecified route of administration in arm right on 23Mar2021 03:45 PM as dose 1, single (age at vaccination: 37 years) for COVID-19 immunisation. No other vaccine in four weeks. It was unknown if covid prior vaccination and did not test covid post vaccination. On 13Apr2021 11:00 AM, the patient experienced right arm stiff and sore, dry painful eyes, sweats and chills, headache, tired, sore throat, dizziness (off balance). No treatment was received. Last menstrual date was 15Sep2020. The mother reported she became pregnant while taking bnt162b2. The mother was 30 Weeks pregnant at the onset of the event.  The mother was due to deliver on 23Jun2021. The mother delivered the pregnancy on 23Jun2021. The clinical outcome of the events was unknown.  No follow-up attempts are possible, No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hyperhidrosis, Maternal exposure during pregnancy, Musculoskeletal stiffness
Clinical narrative: Pregnant at the time of vaccination?: Yes; chills; Right arm stiff and sore; Right arm stiff and sore; dry painful eyes; dry painful eyes; dizziness (off balance); sweats; headache; tired; sore throat; dizziness (off balance); This is a spontaneous report from a Contactable consumer. This 37-years-old Female consumer reported for herself. A 37-year-old pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: ER2613) via an unspecified route of administration in arm left on 13Apr2021 08:45 as dose 2, single (age at vaccination: 37 years) for COVID-19 immunisation. Medical history included known allergies: nuts, IIH, epilepsy, psoriatic arthritis, RA, hashimoto's, hypertension, all from an unknown date and unknown if ongoing. Concomitant medications included certolizumab pegol (CIMZIA); hydroxychloroquine phosphate (PLAQUENIL [HYDROXYCHLOROQUINE PHOSPHATE]); levetiracetam dihydrochloride (KEPPRA [LEVETIRACETAM DIHYDROCHLORIDE]); labetalol hydrochloride (LABETALOL HYDROCHLORIDE); acetazolamide (DIAMOX [ACETAZOLAMIDE]); levothyroxine sodium (SYNTHROID), all taken for an unspecified indication, start and stop date were not reported. Historical vaccine included bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EN6208) via an unspecified route of administration in arm right on 23Mar2021 03:45 PM as dose 1, single (age at vaccination: 37 years) for COVID-19 immunisation. No other vaccine in four weeks. It was unknown if covid prior vaccination and did not test covid post vaccination. On 13Apr2021 11:00 AM, the patient experienced right arm stiff and sore, dry painful eyes, sweats and chills, headache, tired, sore throat, dizziness (off balance). No treatment was received. Last menstrual date was 15Sep2020. The mother reported she became pregnant while taking bnt162b2. The mother was 30 Weeks pregnant at the onset of the event.  The mother was due to deliver on 23Jun2021. The mother delivered the pregnancy on 23Jun2021. The clinical outcome of the events was unknown.  No follow-up attempts are possible, No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain in extremity
Clinical narrative: Pregnant at the time of vaccination?: Yes; chills; Right arm stiff and sore; Right arm stiff and sore; dry painful eyes; dry painful eyes; dizziness (off balance); sweats; headache; tired; sore throat; dizziness (off balance); This is a spontaneous report from a Contactable consumer. This 37-years-old Female consumer reported for herself. A 37-year-old pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: ER2613) via an unspecified route of administration in arm left on 13Apr2021 08:45 as dose 2, single (age at vaccination: 37 years) for COVID-19 immunisation. Medical history included known allergies: nuts, IIH, epilepsy, psoriatic arthritis, RA, hashimoto's, hypertension, all from an unknown date and unknown if ongoing. Concomitant medications included certolizumab pegol (CIMZIA); hydroxychloroquine phosphate (PLAQUENIL [HYDROXYCHLOROQUINE PHOSPHATE]); levetiracetam dihydrochloride (KEPPRA [LEVETIRACETAM DIHYDROCHLORIDE]); labetalol hydrochloride (LABETALOL HYDROCHLORIDE); acetazolamide (DIAMOX [ACETAZOLAMIDE]); levothyroxine sodium (SYNTHROID), all taken for an unspecified indication, start and stop date were not reported. Historical vaccine included bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EN6208) via an unspecified route of administration in arm right on 23Mar2021 03:45 PM as dose 1, single (age at vaccination: 37 years) for COVID-19 immunisation. No other vaccine in four weeks. It was unknown if covid prior vaccination and did not test covid post vaccination. On 13Apr2021 11:00 AM, the patient experienced right arm stiff and sore, dry painful eyes, sweats and chills, headache, tired, sore throat, dizziness (off balance). No treatment was received. Last menstrual date was 15Sep2020. The mother reported she became pregnant while taking bnt162b2. The mother was 30 Weeks pregnant at the onset of the event.  The mother was due to deliver on 23Jun2021. The mother delivered the pregnancy on 23Jun2021. The clinical outcome of the events was unknown.  No follow-up attempts are possible, No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Flushing, Hyperhidrosis
Clinical narrative: Flushed face; Sudden heavy sweating; Sudden feeling of skin being hot especially in the back of neck; Sudden feeling of skin being hot especially in face.; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewols8, expiration date: Jul2021) via an unspecified route of administration in the left arm on 11Apr2021 at 10:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as none. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021 at 10:15, the patient experienced a flushed face, sudden heavy sweating and sudden feeling of skin being hot especially in the back of neck and face. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with ice pack on neck and on top of head. The clinical outcome of the events flushed face, sudden heavy sweating and sudden feeling of skin being hot especially in the back of neck and face was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Varicose vein
Clinical narrative: Awkward and very uncomfortable armpit pain; Lymph node swelling in the left armpit; Darker vein appear close to the skin on the same arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 08:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medication included daily vitamin (unspecified) taken for an unknown indication on an unknown date and unknown if ongoing. The patient previously received erythromycin (MANUFACTURER UNKNOWN) for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, the patient experienced awkward and very uncomfortable armpit pain and lymph node swelling in the left armpit, the same arm as the vaccine. Extremely uncomfortable to the point that the patient had to take a sleeping aid. It happened on day 3 and had lasted 3 days at the time of this report. On an unknown date in Apr2021, the patient also had a darker vein appear close to the skin on the same arm and did contact her doctor but had not heard back at the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken for awkward and very uncomfortable armpit pain and lymph node swelling in the left armpit and included treatment with unspecified sleeping aid on an unknown date. The clinical outcome of the events awkward and very uncomfortable armpit pain and lymph node swelling in the left armpit were recovered on 14Apr2021 while the event darker vein appear close to the skin on the same arm was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest pain
Clinical narrative: Severe chest pain; Severe back pain between shoulder blades; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on 11Apr2021 at 14:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medication. The patient had no known allergies to medications, food or other products. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 21Mar2021 at 13:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 15:30, the patient experienced severe chest pain and severe back pain between shoulder blades. The patient did not receive any treatment for the events. The clinical outcome of the events severe chest pain and severe back pain between shoulder blades were unknown.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives on legs, hips, torso and underarms; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 29Mar2021 at 11:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included ethinylestradiol, levonorgestrel (SRONYX) since an unknown start date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 29Mar2021 the patient experienced hives at night only on legs, hips, torso and underarms up to 2 weeks after initial vaccination. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event hives on legs, hips, torso and underarms was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Sciatica
Clinical narrative: Moderate to severe sciatic pain; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP1534) via an unspecified route of administration in the left arm on 23Mar2021 at 11:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis, sciatica, knee surgery, neck surgery and back surgery on unknown dates. The patient did not have any allergies to food, medications, or other products. Concomitant medications included ibuprofen (ADVIL) started on an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021 at 16:00, the patient experienced moderate to severe sciatic pain on the left side from lower back through left leg which started about 30 hours after the shot and lasted 3 days. She applied heat and topical ointment as well as ibuprofen and pain subsided after 3 days. She had history of sciatica but the pain was only on the side that where she got the vaccine. She believed it was a side effect from the vaccine, plus the fact that she did not have that pain prior to getting the vaccine. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were taken as a result of moderate to severe sciatic pain and included treatment with heat, topical ointment and ibuprofen. The clinical outcome of the event moderate to severe sciatic pain was recovered on 27Mar2021.   No follow-up attempts are needed. No further information is expected.